Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
30 point » 3d point (Expand Search), 50 points (Expand Search), _ point (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
30 point » 3d point (Expand Search), 50 points (Expand Search), _ point (Expand Search)
-
1201
Overexpression of TNFAIP9 counteracted the renal damage caused by 5/6 Nx in C57 mice.
Published 2025Subjects: -
1202
-
1203
-
1204
-
1205
-
1206
-
1207
Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX
Published 2021“…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
-
1208
Effects of Y-P30 on expression and phosphorylation of glutamate receptors, Src, and ERK.
Published 2019“…<p>(A-C) Qualitative (A) and quantitative (B, C) results of 15 and 60 min single-pulse treatment with Y-P30 at DIV 5, DIV 10 and DIV 20. …”
-
1209
-
1210
-
1211
EIS impedance of (a) Gadolinium-doped ceria and (b) Lanthanum strontium cobalt oxide.
Published 2025Subjects: -
1212
DC conductivity of (a) Gadolinium-doped ceria and (b) Lanthanum strontium cobalt oxide.
Published 2025Subjects: -
1213
XRD pattern of (a) Gadolinium-doped ceria and (b) Lanthanum strontium cobalt oxide.
Published 2025Subjects: -
1214
-
1215
Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study
Published 2020“…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”
-
1216
Irbesartan Decreases <sup>14</sup>C-FDG and <sup>99m</sup>Tc-annexin A5 Accumulation Levels.
Published 2014Subjects: -
1217
-
1218
-
1219
-
1220